Naseem Ali, medical affairs lead for XTANDI at Astellas Australia, said, “Prostate cancer is currently the most diagnosed cancer in Australia and continues to be a major health burden, but these findings signal a meaningful step forward in improving outcomes for men facing the disease."
Australian-led ENZAMET prostate cancer trial to be presented at ASCO 2025
May 27, 2025 Latest NewsBioPharma
Latest Video
New Stories
-
The Dispatched 'Week in Review' Podcast - 3 October
October 3, 2025 - - Podcast -
The challenge is for our gatekeepers. Can they see beyond the gate?
October 3, 2025 - - Latest News -
Trump administration links MFN and lower prices to faster FDA approvals
October 3, 2025 - - Latest News -
Vertex appoints Elisha Whitfield as senior country manager for Australia and New Zealand
October 2, 2025 - - Latest News -
Race Oncology uncovers novel anticancer mechanism for bisantrene
October 2, 2025 - - Australian Biotech -
Mark Butler announces boost for clinical trial reform, after years of delay
October 2, 2025 - - Latest News -
Pharmac moves to ease access to HIV medicines in New Zealand
October 2, 2025 - - Latest News